🔓 Unlock the full profile of Kelly Foote (University Of Florida College Of Medicine), including verified contact details, financial insights, and professional associations.

See Kelly Foote Full Profile

Below are the ✅ Verified Contact Details to help you connect directly:

Email: kel*****@uni******.com

Mobile: 87459*****

Estimated Net Worth 💰 : ₹0 – ₹500+ Cr (approx. $0 – $60M)

Key Insights You Should Know About This Individual

  • Kelly Foote serves as the Founder and Co-Director at the University of Florida College of Medicine, a role that signifies leadership in a premier institution focused on medical education and research.
  • Before the current position, Kelly Foote was the Director of the University of Florida Stereotactic and Functional Neurosurgery Fellowship, contributing to the training and development of future neurosurgeons from 2009.
  • In 2002, Kelly Foote co-founded the Norman Fixel Institute for Neurological Diseases, reflecting a commitment to advancing the understanding and treatment of neurological conditions.
  • Kelly Foote also held a position as a Professor of Neurosurgery at the University of Florida College of Medicine since 2002, indicating a significant academic role that influences both education and research in neurosurgery.
  • Under Kelly Foote's leadership, the University of Florida College of Medicine has experienced notable organizational growth, including a 7.9% growth over a 24-month period.
  • The work of Kelly Foote in the field of neurosurgery has likely addressed various challenges, including the advancement of surgical techniques and the integration of new technologies in patient care.
  • Kelly Foote's contributions in both clinical practice and medical education are instrumental in enhancing the reputation of the University of Florida College of Medicine as a leader in neurosurgical training and research.
  • By fostering a collaborative environment within academic and clinical settings, Kelly Foote has played a key role in driving innovation and improving outcomes for patients with neurological diseases.